CLDX EBITDA Growth
Celldex Therapeutics Inc · EBITDA Growth
CLDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-51.43%period ending
CLDX TTM EBITDA YoY % (25.00% → -51.43%)
Year-over-year change
High-resolution chart · PNG
CLDX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -51.4266% | |
| -59.653% | |
| -65.1216% | |
| -54.8869% | |
| -41.2591% | |
| -31.3843% | |
| -18.7681% | |
| -17.3337% | |
| -25.9555% | |
| -24.2666% | |
| -27.8261% | |
| -26.9117% | |
| -25.0034% | |
| -45.9576% | |
| -54.1919% | |
| -71.8967% | |
| -76.0444% | |
| -48.6793% | |
| -44.7726% | |
| -17.0324% | |
| -5.3222% | |
| -3.5349% | |
| 8.0999% | |
| 6.9011% | |
| 9.0157% | |
| 24.6232% | |
| 31.591% | |
| 39.3633% | |
| 43.6793% | |
| 34.0366% | |
| 30.2008% | |
| 22.1795% | |
| 19.3909% | |
| 19.7347% | |
| 16.4676% | |
| 14.9129% | |
| 11.2464% | |
| 7.8712% | |
| 0.8022% | |
| -2.5273% | |
| -5.9756% | |
| -9.9259% | |
| -7.7243% | |
| -16.5472% | |
| -22.7962% | |
| -31.6247% | |
| -48.4503% | |
| -46.2321% | |
| -54.834% | |
| -52.3924% | |
| -43.7437% | |
| -46.299% | |
| -40.0783% | |
| -38.9952% | |
| -40.5927% | |
| -13,755% | |
| -2,475.7748% | |
| -1,501.4187% | |
| -932.6259% | |
| 98.9525% | |
| 105.8676% | |
| 109.1726% | |
| 114.1064% | |
| -20.3586% | |
| -10.4323% | |
| -5.0729% | |
| -5.1088% | |
| 1.5048% | |
| -20.9486% | |
| -85.34% | |
| -125.6506% | |
| -84.533% | |
| -38.4882% | |
| 22.3756% | |
| 31.2188% | |
| 10.207% | |
| -11.6121% | |
| -51.1231% | |
| -21.1306% | |
| -6.52% | |
| -1.5382% | |
| 3.5815% | |
| -41.0328% | |
| -46.4761% | |
| -65.1598% | |
| -72.5981% | |
| -16.3453% | |
| -4.7742% | |
| -6.0552% | |
| 22.1943% | |
| 20.3791% | |
| 33.6865% | |
| 59.4845% | |
| 51.0908% | |
| 42.568% | |
| 21.6896% | |
| -19.2485% | |
| -45.4735% | |
| -57.8493% | |
| -59.1074% |